Medtronic plc vs. Neuraxis, Inc.
Medtronic plc (MDT) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| MDT | NRXS | |
|---|---|---|
| Market Cap | $116.35 billion | $87.15 million |
| Revenue (TTM) | — | $5.32 million |
| Net Income (TTM) | — | $-7,678,631 |
MDT leads on 1 of 1 size & scale factors.
Valuation
| MDT | NRXS | |
|---|---|---|
| Price / Book | 2.29 | 12.94 |
| Price / Sales | — | 16.39 |
MDT leads on 1 of 1 valuation factors.
Profitability
| MDT | NRXS | |
|---|---|---|
| Net Margin | — | -144.44% |
| Return on Equity | — | -114.01% |
MDT and NRXS split the profitability factors evenly.
Dividend
| MDT | NRXS | |
|---|---|---|
| Dividend Yield | 3.17% | — |
MDT and NRXS split the dividend factors evenly.
Risk & Sentiment
| MDT | NRXS | |
|---|---|---|
| Short Interest | 0.62% | 0.02% |
NRXS leads on 1 of 1 risk & sentiment factors.
Dig deeper: MDT overview, MDT financials, NRXS overview, NRXS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.